Mission

Make life more beautiful.

More about Mentor

Mentor Worldwide LLC

A Global Leader in Aesthetic Medicine

Founded in 1969, Mentor Worldwide LLC is a leading supplier of medical products for the global aesthetic medicine market. The Company develops, manufactures and markets innovative, science-based products for aesthetics markets around the world.

Headquartered in Santa Barbara, California, Mentor has manufacturing and research operations in the United States, Mauritius, and the Netherlands.

Mentor has made breast implant devices for more than 20 years. Mentor's breast implants are for use in both breast augmentation and breast reconstruction and are of the highest quality, and made under strict standards of design and testing. Because of this, Mentor has achieved a tremendous level of respect in the medical community and is consistently recognized by physicians for outstanding product integrity. Learn about MemoryGel^® Breast Implants – our popular, US Food and Drug Administration approved silicone implant.

Mentor continues to launch important line extensions to its existing products that add value to doctors and patients. In addition, the Company has made a number of strategic acquisitions and established key partnerships to expand its product portfolio. Mentor has leveraged its leadership position in aesthetics to expand into the cosmetic dermatology market. The Company has acquired a range of next generation, non-animal, synthetic hyaluronic acid-based dermal filler products. Mentor has also acquired broad rights to a range of highly purified, next generation botulinum toxin products. Mentor continues to expand its product portfolio through internal innovation.

OUR MISSION

Make life more beautiful.

A LONG PROUD HERITAGE

Mentor began as an urology company based in Minneapolis, Minnesota. The Company started with four employees and initial capital of $50,000 and went public in 1970.

GLOBAL PRESENCE

International sales rose steadily during the 1980s, and took a dramatic leap in 1991 following the opening of direct sales offices in Germany, Australia, the United Kingdom and Canada. In 1993, the Company selected a European manufacturing site in Leiden, The Netherlands, which became operational in 1994.

MENTOR GROWS INTO NEW, EXCITING AREAS

Mentor’s business also includes a line of lipoplasty products for body aesthetics. Mentor has expanded into the cosmetic dermatology market with the addition of PREVELLE^® Silk Dermal Filler, a hyaluronic acid (HA)-based dermal filler that includes lidocaine to reduce the pain of injection.

On Jan 23, 2009, Mentor was acquired by Johnson & Johnson and is a stand-alone business unit reporting through Ethicon Inc., a leading provider of suture, mesh, hemostats and other products for a wide range of surgical procedures. By joining forces, we aspire to be the trusted global leader in aesthetic medicine among both consumers and professionals by providing a broad range of innovative, science and clinical-based solutions to maintain, enhance, and restore self-esteem and quality of life. Simply said, our goal is to make life more beautiful.

Research and Development

text

News

Media

For all media inquiries contact:

Director, Corporate Communication
c/o Mentor Worldwide LLC
201 Mentor Drive
Santa Barbara, CA 93111
T: 805.879.6000

All non-media inquiries, click here.

Press Releases

JUNE 14, 2013 MENTOR RECEIVES FDA APPROVAL FOR MENTOR ® MEMORYSHAPE ™ BREAST IMPLANTS Newly Available Teardrop-Shaped Breast Implants Provide Natural Silhouette and Youthful Feel Read More

JUNE 19, 2012 MENTOR WORLDWIDE LLC AND BROOKE BURKE-CHARVET PARTNER TO INTRODUCE NEW INTERACTIVE TOOL FOR WOMEN CONSIDERING BREAST AUGMENTATION SURGERY SANTA BARBARA, Calif. – June 18, 2012 – Mentor Worldwide LLC today announced a new educational campaign featuring mom, actress and entrepreneur Brooke Burke-Charvet. As part of the campaign, Burke-Charvet will introduce a first-of-its-kind interactive tool – the New You Visualizer – which helps women see their new look before moving forward with consultation and augmentation surgery. Read More

JANUARY 15, 2012 Mentor Statement on PIP Breast Implants   Read More

JANUARY 27, 2011 MENTOR STATEMENT: Mentor’s first priority has and always will be patient safety. We fully support the U.S. Food and Drug Administration’s (FDA) efforts to gather additional data and study ALCL (anaplastic large cell lymphoma) in patients with breast implants. According to today’s FDA report, there are about “60 ALCL cases worldwide [though] that number is difficult to verify.” FDA also estimates that 5 to 10 million women worldwide have breast implants. Mentor has been monitoring very closely case reports of patients with ALCL, (a rare form of non-Hodgkins lymphoma) since reports first appeared in the medical literature regarding this condition. Mentor has provided and continues to provide information to FDA and other regulatory agencies about the safety of its products. Mentor concurs with FDA’s position that, “because the risk of ALCL appears very small, FDA believes that the totality of evidence continues to support a reasonable assurance that FDA-approved breast implants are safe and effective when used as labeled.” Read More

Contact Us

Mailing Address: Mentor Worldwide LLC 201 Mentor Drive Santa Barbara, CA 93111	For general inquiries: Toll Free: 800.525.0245 Local: 805.879.6000 Monday-Friday 5:30 a.m. - 4:30 p.m. PDT
Residents Information: http://www.mentorwwllc.com/global-us/Residents.aspx Clinical Study Enrollment/Eligibility: https://register.clinicaltrials.gov General Inquiries: webmaster@mentorwwllc.com

Patient Inquiries

Warranty Information: 1-800-MENTOR8 or 1-800-636-8678 Email: askmentor@mentorcorp.com Monday-Friday 8:00 a.m. – 5:00 p.m. PST

International Inquiries

Please Select Region

Europe, Middle East and Africa Asia Pacific Canada

Aesthetic Products Distributors

Latin America
mentorLA@its.jnj.com or mentorbrasil@its.jnj.com

Asia
xchen1@its.jnj.com